Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1α

被引:54
作者
Su, Wenjing [2 ,3 ]
Huang, Lei [1 ]
Ao, Qilin [2 ,3 ]
Zhang, Qinghua [1 ]
Tian, Xun [1 ]
Fang, Yong [4 ]
Lu, Yunping [4 ]
机构
[1] Cent Hosp Wuhan, Dept Obstet & Gynecol, Wuhan 430014, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Inst Pathol, Wuhan 430030, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan 430030, Hubei, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Ctr, Wuhan 430030, Hubei, Peoples R China
基金
美国国家科学基金会;
关键词
Noscapine; HIF-1; alpha; Ovarian neoplasm; Cisplatin; Chemoresistance; HYPOXIA-INDUCED CHEMORESISTANCE; MEDIATED APOPTOSIS; INDUCIBLE FACTOR-1; DRUG-RESISTANCE; FACTOR; 1-ALPHA; IN-VITRO; PATHWAY; ANGIOGENESIS; LYMPHOMA; PROTEIN;
D O I
10.1016/j.canlet.2011.02.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is closely related with chemoresistance of solid tumors. The purpose of this study was to investigate the ability of noscapine to inhibit HIF-1 alpha and sensitize ovarian cancer cells to cisplatin (DDP) under hypoxic conditions. Herein, we report that noscapine sensitized cobalt-induced chemoresistant ovarian cancer cells to DDP-induced apoptosis and inhibition of cell proliferation. Noscapine also promoted proteasome-mediated degradation of cobalt-stabilized HIF-1 alpha protein, with subsequent inhibition of HIF-1 transcriptional activity. These data establish noscapine as a small molecule inhibitor of HIF-1 alpha and provide an evidence for its combination with DDP in combating ovarian cancer chemoresistance. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 29 条
[1]   Noscapine and diltiazem augment taxol and radiation-induced S-phase arrest and clonogenic death of C6 glioma in vitro [J].
Altinoz, Meric A. ;
Bilir, Ayhan ;
Del Maestro, Rolando F. ;
Tuna, Sevilcan ;
Ozcan, Emin ;
Gedikoglu, Gunduz .
SURGICAL NEUROLOGY, 2006, 65 (05) :478-485
[2]   Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and t-cell lymphoma [J].
Aneja, Ritu ;
Vangapandu, Surya N. ;
Lopus, Manu ;
Chandra, Ramesh ;
Panda, Dulal ;
Joshi, Harish C. .
MOLECULAR PHARMACOLOGY, 2006, 69 (06) :1801-1809
[3]   Pim-1 plays a pivotal role in hypoxia-induced chemoresistance [J].
Chen, J. ;
Kobayashi, M. ;
Darmanin, S. ;
Qiao, Y. ;
Gully, C. ;
Zhao, R. ;
Yeung, S. C. ;
Lee, M. H. .
ONCOGENE, 2009, 28 (28) :2581-2592
[4]  
Comerford KM, 2002, CANCER RES, V62, P3387
[5]   Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis [J].
Di Stefano, V ;
Rinaldo, C ;
Sacchi, A ;
Soddu, S ;
D'Orazi, G .
EXPERIMENTAL CELL RESEARCH, 2004, 293 (02) :311-320
[6]   Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1α [J].
Huang, Lei ;
Ao, Qilin ;
Zhang, Qinghua ;
Yang, Xiaokui ;
Xing, Hui ;
Li, Fang ;
Chen, Gang ;
Zhou, Jianfeng ;
Wang, Shixuan ;
Xu, Gang ;
Meng, Li ;
Lu, YunPing ;
Ma, Ding .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (03) :447-456
[7]   Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway [J].
Kallio, PJ ;
Wilson, WJ ;
O'Brien, S ;
Makino, Y ;
Poellinger, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6519-6525
[8]   Treatment options in the management of ovarian cancer [J].
Kikuchi, Y ;
Kita, T ;
Takano, M ;
Kudoh, K ;
Yamamoto, K .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (05) :743-754
[9]   An Akt/Hypoxia-Inducible Factor-1α/Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells [J].
Lau, Chi Keung ;
Yang, Zhen Fan ;
Ho, David W. ;
Ng, Michael N. ;
Yeoh, George C. T. ;
Poon, Ronnie T. P. ;
Fan, Sheung Tat .
CLINICAL CANCER RESEARCH, 2009, 15 (10) :3462-3471
[10]   2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF [J].
Mabjeesh, NJ ;
Escuin, D ;
LaVallee, TM ;
Pribluda, VS ;
Swartz, GM ;
Johnson, MS ;
Willard, MT ;
Zhong, H ;
Simons, JW ;
Giannakakou, P .
CANCER CELL, 2003, 3 (04) :363-375